{"disease":{"id":"transient-insomnia","name":"transient insomnia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05253417","title":"The CANabidiol Use for RElief of Short Term Insomnia","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":208,"lead_sponsor_name":"Bod Australia","has_results":false},{"nct_id":"NCT03331042","title":"SM-1 vs 2 Comparators and Placebo in Participants With a History of Transient Insomnia.","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":85,"lead_sponsor_name":"Sequential Medicine Ltd","has_results":true},{"nct_id":"NCT04396327","title":"SM-1 vs. an Active Comparator in A Model of Transient Insomnia","phase":"PHASE2","overall_status":"NOT_YET_RECRUITING","enrollment_count":14,"lead_sponsor_name":"Sequential Medicine Ltd","has_results":false},{"nct_id":"NCT05457790","title":"Feasibility and Preliminary Efficacy of Acceptance and Commitment Therapy (ACT) for Sleep Disturbances in Adults With Sickle Cell Disease (SCD)","phase":"NA","overall_status":"SUSPENDED","enrollment_count":3,"lead_sponsor_name":"National Cancer Institute (NCI)","has_results":false}],"total":4},"guidelines":[],"source":"Drug Landscape verified database"}